Neuroradiology: Page 225

CT perfusion studies can identify patients at risk of hemorrhage from thrombolytic therapy

By Edward Susman

CHICAGO - Quantitative CT perfusion imaging appears to give doctors a means to determine if the patient suffering an acute stroke is at risk of suffering hemorrhage with thrombolytic therapy.

November 29, 2003

MRI, MRS piece together neurological damage in chemical solvent abusers

By Shalmali Pal

The health problems associated with toluene abuse are undeniable -- toxic encephalopathy, cognitive impairment, cerebellar dysfunction, parkinsonism, and hearing loss, to name a few.

November 19, 2003

3-D ultrasound shows promise in neonatal, pediatric neurosonography

By Erik L. Ridley

Austrian and U.S. researchers found a number of benefits to 3-D pediatric ultrasound in a study of the technology published in European Radiology. The researchers compared 3-D scanning to 2-D ultrasound, and to other modalities like CT and MRI.

November 3, 2003

Same parts of brain say "ouch" when hurt physically or emotionally

Using functional MRI and a clever experimental design, California researchers have shown that the experience of being left out activates the same brain machinery as being physically hurt. They published their results in Science.

October 23, 2003

BrainLab, Rad Technology ink deal

By AuntMinnie.com staff writers

Image-guided surgery firm BrainLab and radiation therapy provider Rad Technology have signed a cooperation agreement. Rad Technology of Pembroke Pines, FL will offer its portable radiation oncology system to BrainLab’s Novalis shaped-beam surgery customers worldwide.

October 19, 2003

NIH awards grants to Molecular Insight

By AuntMinnie.com staff writers

Radioisotope imaging developer Molecular Insight Pharmaceuticals has received grants from the U.S. National Institutes of Health for three new research projects, according to the Cambridge, MA-based company.

October 15, 2003

Trial questions PET's cost-effectiveness for Alzheimer's diagnosis

By Jonathan S. Batchelor

Based on the results of their analysis, Boston researchers concluded that although PET may have a high diagnostic accuracy for Alzheimer’s diagnosis, adding it to the standard diagnostic regimen at Alzheimer’s disease clinics would yield limited benefits at a very high cost.

September 15, 2003

Functional imaging unlocks secrets of meditation

By Brian Casey

Recent advances in functional imaging technology are opening a window of understanding on the neurological changes that occur during meditative practice.

September 11, 2003

Do meds to slow dementia really work? MRS may hold the answer

By Edward Susman

MR spectroscopy (MRS) can keep Alzheimer’s patients and their physicians up to speed as to whether their medication is actually slowing disease progression, according to two reports at the 2003 International Psychogeriatric Association meeting in Chicago.

September 11, 2003

Illuminating the mind: Imaging explores the mysteries of meditation

By Shalmali Pal

Ten million adults in the U.S. now practice some form of meditation in an effort to cope with the stresses of modern life. In turn, the mental health community is taking a closer look at the effects of meditation on the brain and its function, in a new specialty called neurotheology -- making a direct link between the neurosciences and spiritual experiences.

September 10, 2003

AuntMinnie.com MRI Digital Community Insider

By Shalmali Pal

The number of people in the U.S. suffering from Alzheimer’s disease could top 13 million by 2050, according to recently published research. But the extent to which this will occur depends on the inroads made in Alzheimer’s diagnosis and treatment. Needless to say, the neurology community is already on the case.

September 7, 2003

Loss of brain volume on MR may precede clinical signs of Alzheimer’s

By Shalmali Pal

Brain-volume changes on MRI can be a reliable biomarker for the neuropathology of Alzheimer’s disease, according to a study out of the Oregon Health and Sciences University in Portland. Specifically, the researchers looked at whether the accumulation of senile plaques (SP) and neurofibrillary tangles (NFT) can be used to monitor disease progression in clinical trials.

September 4, 2003

Previous Page

Page 225 of 239

Next Page